Öberg, Kjell

Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors

Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., et al. (2017) · New England Journal of Medicine

Neuroendocrine Tumor Research AdvancesRadiopharmaceutical Chemistry and Applications

Cited by 3,308

ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum

Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology

Neuroendocrine Tumor Research AdvancesGastrointestinal Tumor Research and Treatment

Cited by 474

‘Satisfaction with care’: associations with health-related quality of life and psychosocial function among Swedish patients with endocrine gastrointestinal tumours

ESSEN, L. V., LARSSON, G., ÖBERG, K., & SJÖDÉN, P. O. (2002) · European Journal of Cancer Care

Patient Satisfaction in HealthcareCancer survivorship and care

Cited by 176

On categorization and quantification of women's sexual dysfunctions: An epidemiological approach

Öberg, K., Fugl-Meyer, A. R., & Fugl-Meyer, K. S. (2004) · International Journal of Impotence Research

Sexual function and dysfunction studiesSexuality, Behavior, and Technology

Cited by 157

Adrenal lesion in multiple endocrine neoplasia type 1

Skogseid, B., Rastad, J., Gobl, A., Larsson, C., Backlin, K., Juhlin, C., Åkerström, G., & Öberg, K. (1995) · Surgery

Neuroendocrine Tumor Research AdvancesAdrenal and Paraganglionic Tumors

Cited by 111